Ranbaxy Attacks Recall Demand In Glass Particles Action
Ranbaxy Laboratories Ltd. in New Jersey federal court Tuesday attacked a proposed class action targeting its generic version of Lipitor, questioning the honesty of patients allegedly harmed by pills potentially tainted...To view the full article, register now.
Already a subscriber? Click here to view full article